A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
NCT05592626
Abdominal Neoplasm, Abdominal Neoplasms
Sacramento, California, United States
View Trial Details